Pretomanid
Cross-source consensus on Pretomanid from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Risks & contraindications
Comparisons
Highlighted claims
- Pretomanid's adverse event profile includes gallbladder and pancreatic signals in addition to shared cardiac and hepatic signals. — Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database
- Pretomanid unique signals included cholecystitis, pancreatitis, leukocytosis, acute kidney injury, and multiple organ dysfunction syndrome. — Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database
- Pretomanid showed the highest signals among the three drugs for supraventricular extrasystoles and acute cardiac failure. — Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database
- Acute kidney injury was detected exclusively for pretomanid and is not listed in any approved label for the three drugs. — Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database
- The mechanism of frank pretomanid-associated acute kidney injury in MDR-TB patients remains unknown. — Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database